| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA377233
Max Phase: Preclinical
Molecular Formula: C17H14Cl2N2O
Molecular Weight: 333.22
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: OC1(Cc2ccc(Cl)cc2Cl)c2ccccc2C2=NCCN21
Standard InChI: InChI=1S/C17H14Cl2N2O/c18-12-6-5-11(15(19)9-12)10-17(22)14-4-2-1-3-13(14)16-20-7-8-21(16)17/h1-6,9,22H,7-8,10H2
Standard InChI Key: HVROLNZTLHGLKZ-UHFFFAOYSA-N
Associated Targets(Human)
NFKB2 Tchem Nuclear factor NF-kappa-B complex (2307 Activities)
Associated Targets(non-human)
Adra1d Alpha-1d adrenergic receptor (1475 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Adra1a Alpha-1a adrenergic receptor (3346 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Adra1b Alpha-1b adrenergic receptor (2470 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Human immunodeficiency virus (3636 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
tat Human immunodeficiency virus type 1 Tat protein (75 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Plasmodium falciparum (966862 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 333.22 | Molecular Weight (Monoisotopic): 332.0483 | AlogP: 3.46 | #Rotatable Bonds: 2 |
| Polar Surface Area: 35.83 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 12.15 | CX Basic pKa: 4.49 | CX LogP: 4.10 | CX LogD: 4.10 |
| Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.91 | Np Likeness Score: -0.29 |
References
| 1. del Olmo E, Barboza B, Ybarra MI, López-Pérez JL, Carrón R, Sevilla MA, Boselli C, San Feliciano A.. (2006) Vasorelaxant activity of phthalazinones and related compounds., 16 (10): [PMID:16513345] [10.1016/j.bmcl.2006.02.003] |
| 2. Bedoya LM, del Olmo E, Sancho R, Barboza B, Beltrán M, García-Cadenas AE, Sánchez-Palomino S, López-Pérez JL, Muñoz E, San Feliciano A, Alcamí J.. (2006) Anti-HIV activity of stilbene-related heterocyclic compounds., 16 (15): [PMID:16713260] [10.1016/j.bmcl.2006.04.087] |
| 3. del Olmo E, Barboza B, Chiaradia LD, Moreno A, Carrero-Lérida J, González-Pacanowska D, Muñoz V, López-Pérez JL, Giménez A, Benito A, Martínez AR, Ruiz-Pérez LM, San Feliciano A.. (2011) Antimalarial activity of imidazo[2,1-a]isoindol-5-ol derivatives and related compounds., 46 (11): [PMID:21940072] [10.1016/j.ejmech.2011.08.043] |
Source
Source(1):